Research AppraisalSystematic Review

Role of community pharmacy in the prevention of cardiovascular disease in minority ethnic groups in the UK including barriers and facilitators: a mixed-methods systematic review

BMJ openDuley, Rumanveer Singh, Birdi, Gurkiran Kaur, Bush, Joseph et al.27 May 2026DOI

Clinical Snapshot

70CEBM
Evidence: ModerateSystematic Review

PICO Framework

P — PopulationMinority ethnic groups accessing community pharmacy services and community pharmacy professionals
I — InterventionCommunity pharmacy-based cardiovascular disease prevention interventions
C — ComparatorNo specific comparator (descriptive synthesis of barriers and facilitators)
O — OutcomesBarriers and facilitators to engagement with pharmacy-led CVD prevention services, CVD risk factor management outcomes

Bottom Line

This systematic review identifies significant potential for community pharmacies to address CVD disparities in minority ethnic populations through culturally responsive services. Five key themes emerged: trust relationships, systemic barriers, language concordance, cultural/religious considerations, and family networks. While pharmacies demonstrated capacity for CVD screening, diabetes management, and health promotion, engagement was limited by language barriers, cultural beliefs, and organisational constraints. The evidence base remains limited, particularly for UK contexts, highlighting an urgent need for research into culturally tailored pharmacy interventions. For Australian practice, findings suggest community pharmacies could enhance CVD prevention equity through cultural competence training, multilingual services, and partnership with ethnic community organisations, though robust local evaluation is essential before widespread implementation.

Evidence: Moderate

Key Findings

  • P Value: Not applicable for qualitative synthesis

  • Effect Size: Not applicable for qualitative synthesis

  • Primary Outcome: Five overarching themes: trust, systemic barriers, culturally tailored language, cultural and religious influences, and family and social networks

  • Nnt Or Sensitivity: Thematic saturation achieved across 23 studies with consistent barrier and facilitator identification

  • Confidence Interval: Not applicable for thematic analysis

Clinical Application

Moderate feasibility requiring significant investment in cultural competence training and service redesign Relevant to Australian multicultural communities; aligns with PBS medication management programs and cultural safety initiatives in pharmacy practice Minority ethnic communities accessing community pharmacy services for CVD prevention

Abstract

OBJECTIVES: To evaluate the role of community pharmacy in the prevention of cardiovascular disease (CVD) among minority ethnic groups and to identify key barriers and facilitators influencing engagement with pharmacy-based CVD prevention services. DESIGN: Systematic review using thematic synthesis to analyse both qualitative data and narratively synthesised quantitative data taking a convergent data synthesis approach. Searches were conducted from inception to 16 October 2024 across CINAHL Ultimate (EBSCOhost), EMBASE (Ovid), PubMed (NLM), Scopus (Elsevier) and Web of Science (Clarivate), supplemented by Google Scholar for grey literature and backward and forward citation tracking to identify additional studies. SETTING: Community pharmacy settings across multiple countries, including the UK and international contexts. PARTICIPANTS: Minority ethnic groups accessing community pharmacy services and community pharmacy professionals involved in delivering CVD prevention interventions. INTERVENTIONS: Community pharmacy-based CVD prevention interventions, specifically services addressing CVD risk factors. OUTCOME MEASURES: Outcomes comprised qualitative insights, including barriers and facilitators to engagement with community pharmacy-led CVD prevention services. RESULTS: Twenty-three studies met the eligibility criteria. Five overarching themes were identified: trust, systemic barriers, culturally tailored language, cultural and religious influences and family and social networks. Community pharmacies undertook varied CVD-related roles, most commonly CVD screening and diabetes management with additional contributions to smoking cessation, weight and lipid management, health promotion and medication adherence. Community pharmacies showed potential to support CVD prevention among minority ethnic groups. However, engagement was limited by language barriers, cultural beliefs, lack of trust in healthcare providers and organisational constraints such as time pressures and limited training. Facilitators included culturally tailored interventions, language concordance and strong pharmacist-patient relationships. CONCLUSIONS: Evidence from the UK remains limited, highlighting a need for further research into the role of community pharmacy in reducing CVD disparities among minority ethnic groups. International evidence suggests significant potential for pharmacy-based interventions, but improved cultural competence, targeted service design and greater awareness of determinants of equitable healthcare are essential. Future research should focus on optimising culturally responsive pharmacy-led CVD prevention strategies. PROSPERO REGISTRATION NUMBER: CRD42024579766.

References

  1. 1.Duley, R. S., Birdi, G. K., Bush, J., Shoaib, A., Taylor, C. J., Connolly, D., & Maidment, I. (2026). Role of community pharmacy in the prevention of cardiovascular disease in minority ethnic groups in the UK including barriers and facilitators: a mixed-methods systematic review. BMJ Open. https://doi.org/10.1136/bmjopen-2025-115526
Share:XLinkedIn

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service